investor rights
6 stories related to this topic, newest first.
ai-cio.comLaw Firm Notifies Investors of Securities Class Action Deadlines
A law firm has issued notices for four companies regarding pending securities class actions. Investors must meet specific deadlines to seek lead plaintiff status in each case.
Law Firm Announces Class Action Lawsuit Against Stellantis
Bragar Eagel & Squire, P.C. announced a class action lawsuit filed against Stellantis N.V. in federal court. The suit covers investors who purchased Stellantis common stock between February 26, 2025, and February 5, 2026.
Rosen Law Firm Sets May 26 Deadline for Super Micro Computer Investors in Securities Case
Rosen Law Firm announced a May 26, 2026 deadline for investors who bought Super Micro Computer securities between April 30, 2024 and March 19, 2026 to seek lead plaintiff status in a securities class action. The firm stated that purchasers may be eligible for compensation under a…
Substrate placeholder — needs reviewRosen Law Firm Announces Class Action Lawsuit Against Gossamer Bio for Securities Purchases
Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Gossamer Bio, Inc. securities between June 16, 2025, and February 20, 2026. A lawsuit has already been filed, and affected investors may seek compensation through a contingency fee arrangement. The dea…
Substrate placeholder — needs reviewClass Action Lawsuit Filed Against Gemini Space Station in New York Over IPO Purchases
A class action lawsuit has been filed against Gemini Space Station, Inc. in New York federal court. It targets investors who bought the company's Class A common stock linked to its September 2025 initial public offering. The suit covers purchases from September 12, 2025, to Febru…
Substrate placeholder — needs reviewClass Action Lawsuit Filed Against ImmunityBio for Alleged Securities Fraud
A securities fraud class action lawsuit has been filed against ImmunityBio, Inc. in the United States District Court for the Central District of California. The lawsuit covers investors who purchased or acquired ImmunityBio securities between January 19, 2026, and March 24, 2026.…